These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6811355)

  • 1. Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.
    Rogers HJ; Spector RG; Morrison PJ; Bradbrook ID
    Diabetologia; 1982 Jul; 23(1):37-40. PubMed ID: 6811355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
    Balant L; Fabre J; Zahnd GR
    Eur J Clin Pharmacol; 1975; 8(1):63-9. PubMed ID: 823030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.
    Rydberg T; Jönsson A; Røder M; Melander A
    Diabetes Care; 1994 Sep; 17(9):1026-30. PubMed ID: 7988301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviour of glibenclamide on repeated administration to diabetic patients.
    Balant L; Zahnd GR; Weber F; Fabre J
    Eur J Clin Pharmacol; 1977; 11(1):19-25. PubMed ID: 401739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
    Mück W; Heine PR; Breuel HP; Niklaus H; Horkulak J; Ahr G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):89-94. PubMed ID: 7757317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.
    Kubacka RT; Antal EJ; Juhl RP
    Br J Clin Pharmacol; 1987 Jun; 23(6):743-51. PubMed ID: 3111514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pirprofen on glibenclamide kinetics and response.
    Morrison PJ; Rogers HJ; Spector RG; Bradbrook ID; John VA
    Br J Clin Pharmacol; 1982 Jul; 14(1):123-6. PubMed ID: 6809024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid high-performance liquid chromatography assay of glibenclamide in serum.
    Abdel-Hamid ME; Suleiman MS; el-Sayed YM; Najib NM; Hasan MM
    J Clin Pharm Ther; 1989 Jun; 14(3):181-8. PubMed ID: 2503528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
    Scheen AJ; Jaminet C; Luyckx AS; Lefebvre PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of glibenclamide: heterogeneity in its absorption.
    Ikegami H; Shima K; Tanaka A; Tahara Y; Hirota M; Kumahara Y
    Med J Osaka Univ; 1985 Mar; 35(3-4):55-61. PubMed ID: 3934509
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies.
    Niopas I; Daftsios AC
    J Pharm Biomed Anal; 2002 May; 28(3-4):653-7. PubMed ID: 12008145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of glibenclamide in human plasma and urine.
    Emilsson H; Sjöberg S; Svedner M; Christenson I
    J Chromatogr; 1986 Nov; 383(1):93-102. PubMed ID: 3102535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs.
    Okamoto M; Ogihara N; Kawamura W; Ebihara S; Takiguchi K; Morita T; Uchida R; Yamaguchi J; Sakai T; Okuda Y; Hayashi Y; Arakawa Y; Kikuchi M
    Metabolism; 2002 May; 51(5):575-81. PubMed ID: 11979388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.
    Coppack SW; Lant AF; McIntosh CS; Rodgers AV
    Br J Clin Pharmacol; 1990 Jun; 29(6):673-84. PubMed ID: 2116159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N).
    Neugebauer G; Betzien G; Hrstka V; Kaufmann B; von Möllendorff E; Abshagen U
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):453-60. PubMed ID: 3932228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.